mercaptopurine

Generic: mercaptopurine

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name mercaptopurine
Generic Name mercaptopurine
Labeler mylan pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

mercaptopurine 50 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 0378-3547
Product ID 0378-3547_5a3dbd4a-e02f-4ca5-b23f-9e5c62585e9d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040594
Marketing Start 2005-07-01
Marketing End 2026-05-31

Pharmacologic Class

Classes
nucleic acid synthesis inhibitors [moa] nucleoside metabolic inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03783547
Hyphenated Format 0378-3547

Supplemental Identifiers

RxCUI
197931
UPC
0303783547527
UNII
E7WED276I5

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mercaptopurine (source: ndc)
Generic Name mercaptopurine (source: ndc)
Application Number ANDA040594 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 25 TABLET in 1 BOTTLE, PLASTIC (0378-3547-52)
source: ndc

Packages (1)

Ingredients (1)

mercaptopurine (50 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5a3dbd4a-e02f-4ca5-b23f-9e5c62585e9d", "openfda": {"upc": ["0303783547527"], "unii": ["E7WED276I5"], "rxcui": ["197931"], "spl_set_id": ["15904472-4c32-4224-95d3-eb131a7ff9c8"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 TABLET in 1 BOTTLE, PLASTIC (0378-3547-52)", "package_ndc": "0378-3547-52", "marketing_end_date": "20260531", "marketing_start_date": "20050701"}], "brand_name": "Mercaptopurine", "product_id": "0378-3547_5a3dbd4a-e02f-4ca5-b23f-9e5c62585e9d", "dosage_form": "TABLET", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "0378-3547", "generic_name": "mercaptopurine", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mercaptopurine", "active_ingredients": [{"name": "MERCAPTOPURINE", "strength": "50 mg/1"}], "application_number": "ANDA040594", "marketing_category": "ANDA", "marketing_end_date": "20260531", "marketing_start_date": "20050701"}